Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas

ClinicalTrials.gov ID: NCT02147158

Public ClinicalTrials.gov record NCT02147158. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 3:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ulipristal Acetate for the Intermittent Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the superiority of ulipristal acetate versus placebo for the treatment of abnormal uterine bleeding associated with uterine fibroids

Study identification

NCT ID
NCT02147158
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Allergan
Industry
Enrollment
432 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 29, 2014 (Actual)
Primary completion
Nov 24, 2016 (Actual)
Completion
Nov 24, 2016 (Actual)
Last update posted
Jun 4, 2019

2014 – 2016

United States locations

U.S. sites
61
U.S. states
21
U.S. cities
57
Facility City State ZIP Site status
Watson Investigational Site 138 Mesa Arizona 85209 —
Watson Investigational Site 147 Phoenix Arizona 85032 —
Watson Investigational Site 106 Scottsdale Arizona 85251 —
Watson Investigational Site 124 Tucson Arizona 85712 —
Watson Investigational Site 155 Little Rock Arkansas 72205 —
Watson Investigational Site 155 Encino California 91436 —
Watson Investigational Site 157 Hawaiian Gardens California 90716 —
Watson Investigational Site 134 La Mesa California 91942 —
Watson Investigational Site 127 San Diego California 92111 —
Watson Investigational Site 151 San Diego California 92114 —
Watson Investigational Site 159 Denver Colorado 80209 —
Watson Investigational Site 131 Clearwater Florida 33759 —
Watson Investigational Site 135 Miramar Florida 33027 —
Watson Investigational Site 132 North Miami Florida 33161 —
Watson Investigational Site 161 Orlando Florida 32806 —
Watson Investigational Site 123 Plantation Florida 33324 —
Watson Investigational Site 112 Sarasota Florida 34239 —
Watson Investigational Site 102 Wellington Florida 33414 —
Watson Investigational Site 101 West Palm Beach Florida 33409 —
Watson Investigational Site 160 Atlanta Georgia 30342 —
Watson Investigational Site 103 Sandy Springs Georgia 30328 —
Watson Investigational Site 117 Savannah Georgia 31406 —
Watson Investigational Site 113 Champaign Illinois 61820 —
Watson Investigational Site 119 Schaumburg Illinois 60173 —
Watson Investigational Site 162 Brownsburg Indiana 46112 —
Watson Investigational Site 104 Granger Indiana 46530 —
Watson Investigational Site 150 Covington Louisiana 70433 —
Watson Investigational Site 130 Metairie Louisiana 70001 —
Watson Investigational Site 116 New Orleans Louisiana 70115 —
Watson Investigational Site 108 Las Vegas Nevada 89109 —
Watson Investigational Site 107 Las Vegas Nevada 89128 —
Watson Investigational Site 111 Lawrenceville New Jersey 08648 —
Watson Investigational Site 158 Moorestown New Jersey 08057 —
Watson Investigational Site 115 Albuquerque New Mexico 87109 —
Watson Investigational Site 155 The Bronx New York 10461 —
Watson Investigational Site 126 Durham North Carolina 27713 —
Watson Investigational Site 128 Greensboro North Carolina 27408 —
Watson Investigational Site 145 New Bern North Carolina 28562 —
Watson Investigational Site 146 Raleigh North Carolina 27612 —
Watson Investigational Site 118 Winston-Salem North Carolina 27103 —
Watson Investigational Site 155 Cincinnati Ohio 45267 —
Watson Investigational Site 155 Cleveland Ohio 44106 —
Watson Investigational Site 148 Cleveland Ohio 44122 —
Watson Investigational Site 139 Englewood Ohio 45322 —
Watson Investigational Site 133 Philadelphia Pennsylvania 19114 —
Watson investigational site 142 Pittsburgh Pennsylvania 15206 —
Watson Investigational Site 105 West Reading Pennsylvania 19611 —
Watson Investigational Site 136 Bluffton South Carolina 29910 —
Watson Investigational Site 110 Charleston South Carolina 29425 —
Watson Investigational Site 153 Columbia South Carolina 29201 —
Watson Investigational Site 154 Greenville South Carolina 29615 —
Watson Investigational Site 155 Knoxville Tennessee 37920 —
Watson Investigational Site 122 Dallas Texas 75231 —
Watson Investigational Site 114 Frisco Texas 75035 —
Watson Investigational Site 109 Houston Texas 77030 —
Watson Investigational Site 155 Houston Texas 77054 —
Watson Investigational Site 120 San Antonio Texas 78229 —
Watson Investigational Site 129 Webster Texas 77598 —
Watson Investigational Site 152 Norfolk Virginia 23507-1627 —
Watson Investigational Site 137 Virginia Beach Virginia 23456 —
Watson Investigational Site 121 Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02147158, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2019 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02147158 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →